Sort
141,003 grants matching “cytokine”
The role of the innate immune system on Treg reprogramming in human autoimmune di
$721,853David A. Hafler · Yale University · U01 · FY2016 · AI
Validation and Mechanistic Interrogation of Metabolism Targeting for AD
$721,830Russell H Swerdlow · University Of Kansas Medical Center · R01 · FY2019 · AG
Advanced Non-invasive Imaging in the Investigation of Aortic Stenosis Pathobiology
$721,793Jonathan R Lindner · University Of Virginia · R01 · FY2023 · HL
CNS Viral Persistence and Neuropsychiatric Perturbations in HIV: Single cell and Molecular Interrogation
$721,778Serena S Spudich · Yale University · R01 · FY2021 · MH
COMPLEMENT AND CYTOKINE NETWORK IN LIVER REGENERATION
$721,764John D Lambris · University Of Pennsylvania · P01 · FY2009 · AI
Modulation of Pediatric Sepsis by Virus Persistence
$721,728Jason Brice Weinberg · University Of Michigan At Ann Arbor · R01 · FY2025 · AI
Reverse Metabolomics for the Discovery of Disease Associated Microbial Molecules
$721,727Pieter C Dorrestein · University Of California, San Diego · R01 · FY2024 · DK
Salt Mediated Cross Talk Between Lymphatic Vessels and Immune Cells in Kidney Disease
$721,712Valentina Kon · Vanderbilt University Medical Center · R01 · FY2024 · DK
Lipoproteins and PEDF in the Vascular Complications of Diabetes
$721,707Timothy J Lyons · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2010 · DK
Control of influenza virus induced type I interferon signaling during pregnancy
$721,696Nicholas S Heaton · Duke University · R01 · FY2024 · AI
Development and Testing of New Tuberculosis Vaccines
$721,686Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2010 · AI
Endothelial Injury, BMPR2 Dysfunction and Macrophage Activation Cause EndMT and PAH
$721,683Marlene Rabinovitch · Stanford University · R01 · FY2019 · HL
Determinants of COVID19-induced venous thrombosis and targeted therapy assessed with bioengineered vein-chip
$721,633John H Connor · Boston University Medical Campus · R01 · FY2021 · HL
Discovery and Characterization of Genetic Risk Loci in Sjogren's Syndrome
$721,627Christopher J Lessard · Oklahoma Medical Research Foundation · R01 · FY2024 · AR
Tools for drug efficacy studies in perfused tissue models
$721,610Jelena Vukasinovic · Lena Biosciences, Inc. · R44 · FY2019 · TR
Mechanisms of Vascular Dysfunction in Acute Insulin Resistance
$721,577Joseph A. Vita · Boston University Medical Campus · P50 · FY2007 · HL
Critical Role of Basophils in the Enhancement of the Innate Immune Response during Sepsis
$721,571Adrian M Piliponsky · Seattle Children'S Hospital · R01 · FY2019 · HL
Non-enzymatic post-translational modifications as drivers of AD pathology
$721,551Maciej Walczak · University Of Colorado · R01 · FY2025 · AG
Cannabis use, PrEP and HIV transmission risk Among Black MSM in Chicago
$721,540Dustin T Duncan · Columbia University Health Sciences · R01 · FY2023 · DA
Anti-inflammatory drug target to reduce adverse pregnancy outcomes.
$721,511Suhas Kallapur · University Of California Los Angeles · R01 · FY2019 · HD
Project 1: Immune development and respiratory outcomes in children from diverse Wisconsin communities
$721,493Christine Marie Seroogy · University Of Wisconsin-Madison · U19 · FY2023 · AI
The impact of vaginal washing on cervical inflammation: a randomized controlled trial of women from sub-Saharan Africa at high risk for HIV acquisition.
$721,486Michelle Catherine Sabo · University Of Washington · R01 · FY2024 · HD
Effect of randomized cocoa supplementation on inflammaging and epigenetic aging
$721,458Yanbin Dong · Augusta University · R01 · FY2023 · HL
Mechanisms of cancer immunotherapy-associated thrombosis
$721,398Keith R. McCrae · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · HL
Gamma Delta T cell and microbial modulation to target chronic SIV-associated inflammation
$721,380Namita Rout · Tulane University Of Louisiana · R01 · FY2025 · DK